Molecular Cancer : Impact Factor & More
eISSN: 1476-4598pISSN: 1476-4598
Open AccessShare this on:
Key Metrics
CiteScore 
52.7
Eigenfactor
0.01 - 0.05
Impact Factor
>= 25
Scite Index
0.94 5-Year SI
SJR
Q1Oncology
SNIP
5.2
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Molecular Cancer
Molecular Cancer Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | BMC |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 3990 | USD 4890 | GBP 3490 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2002 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC0 |
| OA statement | Visit website |
View less
Planning to publish in Molecular Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Molecular Cancer
Advances in improving cancer immunotherapy with nanotechnology: from smart nanoparticles to synergistic combination strategies
- 28 Jul 2026
- Molecular Cancer
Radiotherapy and tertiary lymphoid structures: balancing immune activation and immune damage in cancer immunotherapy.
- 22 Jul 2026
- Molecular cancer
Spatial proteomics reveals four-stage molecular evolution in cancer immunotherapy-related gastritis.
- 21 Jul 2026
- Molecular cancer
ADSL drives fumarate mediated scrib-rictor complex formation to promote metastasis dissemination in triple-negative breast cancer.
- 20 Jul 2026
- Molecular cancer
Evidence of endothelial anergy and T-cell exclusion in microsatellite stable colorectal liver metastases revealed through human hemi-liver perfusion and spatial transcriptomics.
- 20 Jul 2026
- Molecular cancer
RNA modifications in cancer: regulators of tumor evolution and therapeutic response.
- 20 Jul 2026
- Molecular cancer
Advances in improving cancer immunotherapy with nanotechnology: from smart nanoparticles to synergistic combination strategies
- 28 Jul 2026
- Molecular Cancer
Radiotherapy and tertiary lymphoid structures: balancing immune activation and immune damage in cancer immunotherapy.
- 22 Jul 2026
- Molecular cancer
Spatial proteomics reveals four-stage molecular evolution in cancer immunotherapy-related gastritis.
- 21 Jul 2026
- Molecular cancer
ADSL drives fumarate mediated scrib-rictor complex formation to promote metastasis dissemination in triple-negative breast cancer.
- 20 Jul 2026
- Molecular cancer
Evidence of endothelial anergy and T-cell exclusion in microsatellite stable colorectal liver metastases revealed through human hemi-liver perfusion and spatial transcriptomics.
- 20 Jul 2026
- Molecular cancer
RNA modifications in cancer: regulators of tumor evolution and therapeutic response.
- 20 Jul 2026
- Molecular cancer
FAQs on Molecular Cancer
How long has Molecular Cancer been actively publishing? 
What is the publishing frequency of Molecular Cancer?
How many articles did Molecular Cancer publish last year?
What is the eISSN & pISSN for Molecular Cancer?
What is Citescore for Molecular Cancer?
What is SNIP score for Molecular Cancer?
What is the SJR for Molecular Cancer?
Who is the publisher of Molecular Cancer?
